91 related articles for article (PubMed ID: 22789672)
1. 2D-DIGE analysis of sera from transgenic mouse models reveals novel candidate protein biomarkers for human gastric cancer.
Penno MA; Klingler-Hoffmann M; Brazzatti JA; Boussioutas A; Putoczki T; Ernst M; Hoffmann P
J Proteomics; 2012 Dec; 77():40-58. PubMed ID: 22789672
[TBL] [Abstract][Full Text] [Related]
2. Identification and validation of novel candidate protein biomarkers for the detection of human gastric cancer.
Humphries JM; Penno MA; Weiland F; Klingler-Hoffmann M; Zuber A; Boussioutas A; Ernst M; Hoffmann P
Biochim Biophys Acta; 2014 May; 1844(5):1051-8. PubMed ID: 24512919
[TBL] [Abstract][Full Text] [Related]
3. Identification of Serum Biomarkers for Gastric Cancer Diagnosis Using a Human Proteome Microarray.
Yang L; Wang J; Li J; Zhang H; Guo S; Yan M; Zhu Z; Lan B; Ding Y; Xu M; Li W; Gu X; Qi C; Zhu H; Shao Z; Liu B; Tao SC
Mol Cell Proteomics; 2016 Feb; 15(2):614-23. PubMed ID: 26598640
[TBL] [Abstract][Full Text] [Related]
4. Serum angiopoietin-like protein 2 as a potential biomarker for diagnosis, early recurrence and prognosis in gastric cancer patients.
Toiyama Y; Tanaka K; Kitajima T; Shimura T; Imaoka H; Mori K; Okigami M; Yasuda H; Okugawa Y; Saigusa S; Ohi M; Inoue Y; Mohri Y; Goel A; Kusunoki M
Carcinogenesis; 2015 Dec; 36(12):1474-83. PubMed ID: 26420253
[TBL] [Abstract][Full Text] [Related]
5. Systematic search for gastric cancer-specific genes based on SAGE data: melanoma inhibitory activity and matrix metalloproteinase-10 are novel prognostic factors in patients with gastric cancer.
Aung PP; Oue N; Mitani Y; Nakayama H; Yoshida K; Noguchi T; Bosserhoff AK; Yasui W
Oncogene; 2006 Apr; 25(17):2546-57. PubMed ID: 16331256
[TBL] [Abstract][Full Text] [Related]
6. Serum olfactomedin 4 (GW112, hGC-1) in combination with Reg IV is a highly sensitive biomarker for gastric cancer patients.
Oue N; Sentani K; Noguchi T; Ohara S; Sakamoto N; Hayashi T; Anami K; Motoshita J; Ito M; Tanaka S; Yoshida K; Yasui W
Int J Cancer; 2009 Nov; 125(10):2383-92. PubMed ID: 19670418
[TBL] [Abstract][Full Text] [Related]
7. New blood markers detection technology: A leap in the diagnosis of gastric cancer.
Beeharry MK; Liu WT; Yan M; Zhu ZG
World J Gastroenterol; 2016 Jan; 22(3):1202-12. PubMed ID: 26811658
[TBL] [Abstract][Full Text] [Related]
8. Proteomic analysis of infiltrating ductal carcinoma tissues by coupled 2-D DIGE/MS/MS analysis.
Davalieva K; Kiprijanovska S; Broussard C; Petrusevska G; Efremov GD
Mol Biol (Mosk); 2012; 46(3):469-80. PubMed ID: 22888636
[TBL] [Abstract][Full Text] [Related]
9. Proteomic identification of serum biomarkers for gastric cancer using multi-dimensional liquid chromatography and 2D differential gel electrophoresis.
Liu W; Liu B; Cai Q; Li J; Chen X; Zhu Z
Clin Chim Acta; 2012 Jul; 413(13-14):1098-106. PubMed ID: 22446497
[TBL] [Abstract][Full Text] [Related]
10. Comparative proteomics, network analysis and post-translational modification identification reveal differential profiles of plasma Con A-bound glycoprotein biomarkers in gastric cancer.
Uen YH; Lin KY; Sun DP; Liao CC; Hsieh MS; Huang YK; Chen YW; Huang PH; Chen WJ; Tai CC; Lee KW; Chen YC; Lin CY
J Proteomics; 2013 May; 83():197-213. PubMed ID: 23541716
[TBL] [Abstract][Full Text] [Related]
11. Tumor-associated autoantibody signature for the early detection of gastric cancer.
Zayakin P; Ancāns G; Siliņa K; Meistere I; Kalniņa Z; Andrejeva D; Endzeliņš E; Ivanova L; Pismennaja A; Ruskule A; Doniņa S; Wex T; Malfertheiner P; Leja M; Linē A
Int J Cancer; 2013 Jan; 132(1):137-47. PubMed ID: 22684876
[TBL] [Abstract][Full Text] [Related]
12. Serum ENA78/CXCL5, SDF-1/CXCL12, and their combinations as potential biomarkers for prediction of the presence and distant metastasis of primary gastric cancer.
Lim JB; Chung HW
Cytokine; 2015 May; 73(1):16-22. PubMed ID: 25689618
[TBL] [Abstract][Full Text] [Related]
13. Serum proteome profiling reveals SOX3 as a candidate prognostic marker for gastric cancer.
Shen J; Zhai J; Wu X; Xie G; Shen L
J Cell Mol Med; 2020 Jun; 24(12):6750-6761. PubMed ID: 32363730
[TBL] [Abstract][Full Text] [Related]
14. Identification of differentially expressed serum proteins in gastric adenocarcinoma.
Subbannayya Y; Mir SA; Renuse S; Manda SS; Pinto SM; Puttamallesh VN; Solanki HS; Manju HC; Syed N; Sharma R; Christopher R; Vijayakumar M; Veerendra Kumar KV; Keshava Prasad TS; Ramaswamy G; Kumar RV; Chatterjee A; Pandey A; Gowda H
J Proteomics; 2015 Sep; 127(Pt A):80-8. PubMed ID: 25952687
[TBL] [Abstract][Full Text] [Related]
15. Serum proteomic approach for the identification of serum biomarkers contributed by oral squamous cell carcinoma and host tissue microenvironment.
Bijian K; Mlynarek AM; Balys RL; Jie S; Xu Y; Hier MP; Black MJ; Di Falco MR; LaBoissiere S; Alaoui-Jamali MA
J Proteome Res; 2009 May; 8(5):2173-85. PubMed ID: 19284786
[TBL] [Abstract][Full Text] [Related]
16. Mining the gastric cancer secretome: identification of GRN as a potential diagnostic marker for early gastric cancer.
Loei H; Tan HT; Lim TK; Lim KH; So JB; Yeoh KG; Chung MC
J Proteome Res; 2012 Mar; 11(3):1759-72. PubMed ID: 22204653
[TBL] [Abstract][Full Text] [Related]
17. Down-regulated expression of complement factor I: a potential suppressive protein for gastric cancer identified by serum proteome analysis.
Liu W; Liu B; Xin L; Zhang Y; Chen X; Zhu Z; Lin Y
Clin Chim Acta; 2007 Feb; 377(1-2):119-26. PubMed ID: 17067565
[TBL] [Abstract][Full Text] [Related]
18. Identification of tubulin beta chain, thymosin beta-4-like protein 3, and cytochrome b-c₁ complex subunit 1 as serological diagnostic biomarkers of gastric cancer.
Fan NJ; Li K; Liu QY; Wang XL; Hu L; Li JT; Gao CF
Clin Biochem; 2013 Oct; 46(15):1578-84. PubMed ID: 23747515
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of the claudin-18 gene, identified through serial analysis of gene expression data analysis, in gastric cancer with an intestinal phenotype.
Sanada Y; Oue N; Mitani Y; Yoshida K; Nakayama H; Yasui W
J Pathol; 2006 Apr; 208(5):633-42. PubMed ID: 16435283
[TBL] [Abstract][Full Text] [Related]
20. Identification of urinary Gc-globulin as a novel biomarker for bladder cancer by two-dimensional fluorescent differential gel electrophoresis (2D-DIGE).
Li F; Chen DN; He CW; Zhou Y; Olkkonen VM; He N; Chen W; Wan P; Chen SS; Zhu YT; Lan KJ; Tan WL
J Proteomics; 2012 Dec; 77():225-36. PubMed ID: 22986152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]